Cullinan Therapeutics, Inc. ($CGEM)
Fenton Mary Kay โ Chief Financial Officer
Shares
27
Price
$6.49
Total Value
$175.23
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Fenton Mary Kay |
|---|---|
| Title | Chief Financial Officer |
| Transaction Date | Dec 31, 2025 |
| Transaction Code | A Grant/Award |
| Acquired/Disposed | Acquired |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Jan 5, 2026 |
| Document Date | Dec 31, 2025 |
| Shares Purchased | 27 |
| Price per Share | $6.49 |
| Total Value | $175.23 |
| Shares Owned After | 62,028 |
| Derivative | No |
| Accession Number | 0001193125-26-002687 |
| Document | View SEC Filing |